[go: up one dir, main page]

WO2019142062A3 - Synergistic herbal composition with anti-proliferative activity - Google Patents

Synergistic herbal composition with anti-proliferative activity Download PDF

Info

Publication number
WO2019142062A3
WO2019142062A3 PCT/IB2019/050102 IB2019050102W WO2019142062A3 WO 2019142062 A3 WO2019142062 A3 WO 2019142062A3 IB 2019050102 W IB2019050102 W IB 2019050102W WO 2019142062 A3 WO2019142062 A3 WO 2019142062A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
extract
spp
therapeutically effective
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2019/050102
Other languages
French (fr)
Other versions
WO2019142062A2 (en
Inventor
Ashvany Kumar Bansal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shashvi Remedies (opc) Private Ltd
Original Assignee
Shashvi Remedies (opc) Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shashvi Remedies (opc) Private Ltd filed Critical Shashvi Remedies (opc) Private Ltd
Publication of WO2019142062A2 publication Critical patent/WO2019142062A2/en
Publication of WO2019142062A3 publication Critical patent/WO2019142062A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

An aspect of the present disclosure provides a synergistic herbal composition that exhibits an anti-proliferative activity, the composition including: therapeutically effective amount of Neem (Azadirachta spp.); and therapeutically effective amount of Mustard (Brassica spp.). In an embodiment, the composition includes Neem (Azadirachta spp.) in an amount ranging from about.25% to about 99% by weight of the composition. In an embodiment, the composition includes mustard (Brassica spp.) in an amount ranging from about.25% to about 99% by weight of the composition. In an embodiment, the composition further includes therapeutically effective amount of any or a combination of: an extract of myrrh, an extract of lavender, an extract of turmeric, an extract of chamomile, germanium or analogue thereof and cow urine. The composition further comprises camphor and bees wax and any other natural, synthetic or pharmaceutically accepted excipient or combination thereof.
PCT/IB2019/050102 2018-01-18 2019-01-07 Synergistic herbal composition with anti-proliferative activity Ceased WO2019142062A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201821002010 2018-01-18
IN201821002010 2018-01-18

Publications (2)

Publication Number Publication Date
WO2019142062A2 WO2019142062A2 (en) 2019-07-25
WO2019142062A3 true WO2019142062A3 (en) 2019-10-03

Family

ID=67301453

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2019/050102 Ceased WO2019142062A2 (en) 2018-01-18 2019-01-07 Synergistic herbal composition with anti-proliferative activity

Country Status (1)

Country Link
WO (1) WO2019142062A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2595173B (en) 2019-02-15 2023-11-29 Shashvi Remedies Opc Private Ltd Synergistic composition with anti-proliferative activity
CN115500363B (en) * 2022-09-20 2023-06-27 广东省科学院微生物研究所(广东省微生物分析检测中心) Mildew-proof composite composition with synergistic effect and preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100473484B1 (en) * 1995-09-15 2005-07-18 존스 홉킨스 스쿨 오브 메디슨 Glucosinolates and isothiocyanates and sugar extraction methods from mustard plants or seeds, methods for producing cancer chemoprotective foods, pills or tablets, and related chemoprotective foods
WO2015035199A1 (en) * 2013-09-06 2015-03-12 Mayo Foundation For Medical Education And Research Neem compositions used for the treatment of cancer
IN2013KO01414A (en) * 2013-12-13 2015-07-10 Kumar Pareek Pawan

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100473484B1 (en) * 1995-09-15 2005-07-18 존스 홉킨스 스쿨 오브 메디슨 Glucosinolates and isothiocyanates and sugar extraction methods from mustard plants or seeds, methods for producing cancer chemoprotective foods, pills or tablets, and related chemoprotective foods
WO2015035199A1 (en) * 2013-09-06 2015-03-12 Mayo Foundation For Medical Education And Research Neem compositions used for the treatment of cancer
IN2013KO01414A (en) * 2013-12-13 2015-07-10 Kumar Pareek Pawan

Also Published As

Publication number Publication date
WO2019142062A2 (en) 2019-07-25

Similar Documents

Publication Publication Date Title
Hosseini et al. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review
ZA202103074B (en) Formulation based on medicinal plant, or part or extract thereof, use of the formulation and product including said formulation
CL2021003291A1 (en) Mixture of plant extracts for use in the prevention and/or treatment of chronic inflammatory bowel diseases.
WO2012033634A3 (en) Topical skin care formulations comprising plant extracts
WO2019209227A3 (en) Solid oral formulations comprising herbal extracts
BR112018009941A8 (en) plant growth regulatory composition with synergistic effect
CL2020000866A1 (en) Use of compositions containing streptomyces melanosporofaciens agl225 in the control of plant diseases.
PH12018000207B1 (en) A pharmaceutical composition for prevention of diet induced obesity
WO2019142062A3 (en) Synergistic herbal composition with anti-proliferative activity
PH12019501512A1 (en) Use of at least one glycyrrhiza plant-based preparation, an antidote made from same, and the use of said antidote
WO2019083321A3 (en) Composition for antioxidation, anti-inflammation, or osteoclast differentiation inhibition
WO2016056026A3 (en) Synergistic composition for osteoarthritis
AR111181A1 (en) METHODS AND COMPOSITIONS TO IMPROVE PLANT HEALTH AND / OR PLANT PERFORMANCE
Sharma et al. In vitro evaluation of antimicrobial and antioxidant profile of Grewia L. root extracts
BR112019001207A2 (en) vaginal composition comprising a combination of estrogen and vitamin d
MY194258A (en) Fat composition
FR3063872B1 (en) PLANT PYRETHRUM COMPOSITION FOR THE CONTROL OF HARMFUL ARTHROPODS
MX2022004523A (en) CONTROLLED RELEASE FORMULATIONS FOR HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES.
WO2019209228A3 (en) Solid oral compositions comprising dried honey and herbal extracts
MX2019012894A (en) FEED COMPOSITIONS FOR ANIMALS AND METHODS OF USE.
WO2011057421A3 (en) Uses of unifloral ulmo honey extract as a bactericide and a fungicide
MX2021003221A (en) Agricultural pesticide containing.
AU2018266835A1 (en) Antioxidant dietary supplement compositions
MX2020002384A (en) Method for preparing a botanical extract of abscisic acid.
MY210063A (en) Synergistic composition with anti-proliferative activity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19741501

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19741501

Country of ref document: EP

Kind code of ref document: A2